Fexinidazole (Hoe239; Hoe-239) is a novel, potent and nitroimidazole-based antiparasitic agent that has been approved in 2021 by FDA as the first all-oral medication to treat African trypanosomiasis caused by Trypanosoma brucei gambiense. It acts well against diseases in both their initial and advanced stages. Its use in Chagas disease is also supported by some evidence.
Tags: buy Fexinidazole | Fexinidazole supplier | purchase Fexinidazole | Fexinidazole cost | Fexinidazole manufacturer | order Fexinidazole | Fexinidazole distributor